FORGING NEW CHEMISTRY
Forge Therapeutics is a biotechnology company developing novel medicines by combining bioinorganic with medicinal chemistry to target metalloenzymes. Forge has developed a fundamentally new approach for the discovery of metalloenzymes inhibitors by focusing first on the metal in the enzyme active site.
Forge Overview | Blacksmith Platform
LATEST NEWS & ARTICLES
-
Forge Therapeutics receives notice of allowance from U.S. patent and trademark office covering novel chemistry targeting LpxC for the treatment of gram-negative bacterial infections GalleryForge Therapeutics receives notice of allowance from U.S. patent and trademark office covering novel chemistry targeting LpxC for the treatment of gram-negative bacterial infections